CRISPR Therapeutics (CRSP) News Today $54.32 +1.50 (+2.84%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$54.58 +0.26 (+0.47%) As of 08/22/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRSP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period CRISPR Therapeutics AG $CRSP Stake Reduced by Charles Schwab Investment Management Inc.5 hours ago | marketbeat.comCRISPR Therapeutics (CRSP) Reports Increase In Q2 Revenue Despite Wider Net LossesAugust 22 at 8:21 PM | finance.yahoo.comBernstein Remains a Hold on Crispr Therapeutics AG (CRSP)August 20 at 2:38 AM | theglobeandmail.comCathie Wood’s ARK buys Robinhood, CRISPR, sells Genius Sports stockAugust 20 at 2:38 AM | investing.comFox Run Management L.L.C. Acquires New Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)August 19, 2025 | marketbeat.comWhat Makes Crispr Therapeutics Ag (CRSP) a Good Buy?August 18, 2025 | finance.yahoo.comEverSource Wealth Advisors LLC Buys 84,708 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)August 18, 2025 | marketbeat.comHere's How This Forgotten Healthcare Stock Could Generate Life-Changing ReturnsAugust 17, 2025 | fool.comCRISPR Therapeutics AG (NASDAQ:CRSP) Position Lessened by Vestmark Advisory Solutions Inc.August 17, 2025 | marketbeat.comIs CRISPR Therapeutics' (CRSP) Rising Net Loss a Sign of Bold Investment or Growing Pressure?August 16, 2025 | finance.yahoo.comVirtu Financial LLC Takes Position in CRISPR Therapeutics AG (NASDAQ:CRSP)August 15, 2025 | marketbeat.comUpgrading Crispr Therapeutics To Hold Ahead Of A Catalyst-Rich 2H 2025August 14, 2025 | seekingalpha.comBenjamin Edwards Inc. Grows Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)August 14, 2025 | marketbeat.comEquities Analysts Set Expectations for CRSP FY2026 EarningsAugust 12, 2025 | marketbeat.comHC Wainwright Has Positive Estimate for CRSP Q4 EarningsAugust 12, 2025 | marketbeat.comHC Wainwright Issues Optimistic Outlook for CRSP EarningsAugust 12, 2025 | americanbankingnews.comMarket Factors: Beware the high quality stock bubbleAugust 11, 2025 | theglobeandmail.comCrispr Therapeutics AG (CRSP) Gets a Buy from Truist FinancialAugust 10, 2025 | theglobeandmail.comBlair William & Co. IL Has $2.32 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)August 10, 2025 | marketbeat.comCetera Investment Advisers Has $1.97 Million Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)August 10, 2025 | marketbeat.comCrispr Therapeutics Faces Stock Dip Amid Promising DevelopmentsAugust 9, 2025 | msn.comGoldman Sachs Remains a Hold on Crispr Therapeutics AG (CRSP)August 8, 2025 | theglobeandmail.comCantor Fitzgerald Has Weak Forecast for CRSP FY2025 EarningsAugust 8, 2025 | marketbeat.comCRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Westwood Holdings Group Inc.August 8, 2025 | marketbeat.comCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Expected to Rise, Barclays Analyst SaysAugust 7, 2025 | marketbeat.comBrookline Capital Management Estimates CRSP Q3 EarningsAugust 7, 2025 | marketbeat.comLeerink Partnrs Has Pessimistic View of CRSP Q3 EarningsAugust 7, 2025 | marketbeat.comHC Wainwright Raises CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $80.00August 7, 2025 | marketbeat.comFY2027 Earnings Estimate for CRSP Issued By Leerink PartnrsAugust 7, 2025 | marketbeat.comM&M's maker Mars taps CRISPR tech to improve cocoa productionAugust 7, 2025 | seekingalpha.comCRISPR Therapeutics' (CRSP) "Buy" Rating Reiterated at Chardan CapitalAugust 6, 2025 | marketbeat.comCrispr Therapeutics’ CTX112 Study: A Promising Step in Autoimmune Disease TreatmentAugust 6, 2025 | msn.comCRISPR Therapeutics (NASDAQ:CRSP) Shares Gap Down - Should You Sell?August 5, 2025 | marketbeat.comCrispr Therapeutics shares tumble after significant earnings missAugust 5, 2025 | investing.comCRISPR Therapeutics (NASDAQ:CRSP) Price Target Raised to $42.00 at Royal Bank Of CanadaAugust 5, 2025 | marketbeat.comIQ EQ FUND MANAGEMENT IRELAND Ltd Boosts Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)August 5, 2025 | marketbeat.comDecoding CRISPR Therapeutics AG (CRSP): A Strategic SWOT InsightAugust 4, 2025 | gurufocus.comCRISPR Therapeutics (NASDAQ:CRSP) Posts Earnings Results, Beats Expectations By $0.25 EPSAugust 4, 2025 | marketbeat.comCRISPR Therapeutics AG (CRSP) Reports Q2 2025 Financial Results and Clinical Progress | CRSP ...August 4, 2025 | gurufocus.comCRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial ResultsAugust 4, 2025 | globenewswire.comPrivium Fund Management B.V. Purchases 25,100 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)August 3, 2025 | marketbeat.comBanque Cantonale Vaudoise Purchases Shares of 18,579 CRISPR Therapeutics AG (NASDAQ:CRSP)August 3, 2025 | marketbeat.comCRISPR Therapeutics (CRSP) Sees 47% Price Increase Over Last QuarterAugust 2, 2025 | finance.yahoo.comQ2 EPS Forecast for CRISPR Therapeutics Decreased by AnalystAugust 1, 2025 | marketbeat.comBayforest Capital Ltd Takes Position in CRISPR Therapeutics AG (NASDAQ:CRSP)August 1, 2025 | marketbeat.comCathie Wood’s ARK buys Prime Medicine, sells CRISPR stockAugust 1, 2025 | investing.comCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 4.1% - Here's What HappenedJuly 30, 2025 | marketbeat.comThe 3 Things That Matter for CRISPR Therapeutics NowJuly 29, 2025 | msn.comInspire Advisors LLC Invests $459,000 in CRISPR Therapeutics AG (NASDAQ:CRSP)July 29, 2025 | marketbeat.comJim Cramer Says “CRISPR Can Either Triple or Do Nothing”July 29, 2025 | insidermonkey.com Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Email Address CRSP Media Mentions By Week CRSP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRSP News Sentiment▼0.980.66▲Average Medical News Sentiment CRSP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRSP Articles This Week▼914▲CRSP Articles Average Week Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Allogene Therapeutics News Axsome Therapeutics News Beam Therapeutics News Editas Medicine News KALA BIO News Moderna News Intellia Therapeutics News Vertex Pharmaceuticals News Teva Pharmaceutical Industries News Summit Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRSP) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access